TORL-2-307-MAB

· TORL Biotherapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TORL-2-307-MAB, covering 2024-10-22 to 2024-10-22. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer [Phase 1]